E-PaperDr Reddys Laboratories Q4 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01023
- Sector: Biotechnology & Drugs
BSE
6,800.4
-16.75 (-0.25%)
-16.75 (-0.25%)Volume1.81 K
Updated: Thu 25 Jul, 2024 | 10:46:13
NSE
6,790-30.15 (-0.44%)
-30.15 (-0.44%)Volume63.61 K
Updated: Thu 25 Jul, 2024 | 10:31:28
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹7,113.80 Cr.(12.65%)
- Operating Profit₹1,463.50 Cr.(20.11%)
- Profit After Tax₹1,309.80 Cr.(36.41%)
- Operating Margin20.57%(6.62%)
Note: Comparison is on YoY basis
Quarterly - Dr Reddys Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 7,113.80 | 6,789.80 | -1.70% | 6,315.20 | 12.65% |
| Selling/ General/ Admin Expenses Total | 3,207.80 | 2,836.50 | 5.98% | 2,829.20 | 13.38% |
| Depreciation/ Amortization | 367.70 | 323.70 | -1.55% | 315.50 | 16.55% |
| Total Operating Expense | 5,650.30 | 5,175.00 | 1.13% | 5,096.70 | 10.86% |
| Operating Income | 1,463.50 | 1,614.80 | -11.28% | 1,218.50 | 20.11% |
| Net Income Before Taxes | 1,605.20 | 1,637.70 | -12.24% | 1,329.20 | 20.76% |
| Net Income | 1,309.80 | 1,243.90 | -5.15% | 960.20 | 36.41% |
| Diluted Normalized EPS | 77.68 | 75.37 | -6.75% | 60.01 | 29.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01RNFI Services IPO booked over 221 times on the third bidding day, NIIs steal the show; check GMP
3 min read24 Jul 2024 - Markets
02Wall Street today: Lacklustre Tesla & Alphabet results drag Nasdaq down nearly 2%
2 min read24 Jul 2024 - Markets
03Sebi reveals 7 out of 10 intraday trade in cash segment made losses in FY23, 76% traders under 30 years of age
3 min read12:53 AM IST